Literature DB >> 24165931

Biodegradable polymeric micelle-encapsulated quercetin suppresses tumor growth and metastasis in both transgenic zebrafish and mouse models.

Qinjie Wu1, Senyi Deng, Ling Li, Lu Sun, Xi Yang, Xinyu Liu, Lei Liu, Zhiyong Qian, Yuquan Wei, Changyang Gong.   

Abstract

Quercetin (Que) loaded polymeric micelles were prepared to obtain an aqueous formulation of Que with enhanced anti-tumor and anti-metastasis activities. A simple solid dispersion method was used, and the obtained Que micelles had a small particle size (about 31 nm), high drug loading, and high encapsulation efficiency. Que micelles showed improved cellular uptake, an enhanced apoptosis induction effect, and stronger inhibitory effects on proliferation, migration, and invasion of 4T1 cells than free Que. The enhanced in vitro antiangiogenesis effects of Que micelles were proved by the results that Que micelles significantly suppressed proliferation, migration, invasion, and tube formation of human umbilical vein endothelial cells (HUVECs). Subsequently, transgenic zebrafish models were employed to investigate anti-tumor and anti-metastasis effects of Que micelles, in which stronger inhibitory effects of Que micelles were observed on embryonic angiogenesis, tumor-induced angiogenesis, tumor growth, and tumor metastasis. Furthermore, in a subcutaneous 4T1 tumor model, Que micelles were more effective in suppressing tumor growth and spontaneous pulmonary metastasis, and prolonging the survival of tumor-bearing mice. Besides, immunohistochemical and immunofluorescent assays suggested that tumors in the Que micelle-treated group showed more apoptosis, fewer microvessels, and fewer proliferation-positive cells. In conclusion, Que micelles, which are synthesized as an aqueous formulation of Que, possess enhanced anti-tumor and anti-metastasis activity, which can serve as potential candidates for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24165931     DOI: 10.1039/c3nr04651f

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  7 in total

1.  Gold nanoparticle-conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2-mediated pathway in breast cancer.

Authors:  S Balakrishnan; F A Bhat; P Raja Singh; S Mukherjee; P Elumalai; S Das; C R Patra; J Arunakaran
Journal:  Cell Prolif       Date:  2016-09-18       Impact factor: 6.831

2.  Quercetin Remodels the Tumor Microenvironment To Improve the Permeation, Retention, and Antitumor Effects of Nanoparticles.

Authors:  Kaili Hu; Lei Miao; Tyler J Goodwin; Jun Li; Qi Liu; Leaf Huang
Journal:  ACS Nano       Date:  2017-04-21       Impact factor: 15.881

3.  Enhancing the anti-ovarian cancer activity of quercetin using a self-assembling micelle and thermosensitive hydrogel drug delivery system.

Authors:  Guangya Xu; Bin Li; Ting Wang; Jun Wan; Yan Zhang; Jingwei Huang; Yangmei Shen
Journal:  RSC Adv       Date:  2018-06-11       Impact factor: 4.036

Review 4.  Clinical Considerations of Focal Drug Delivery in Cancer Treatment.

Authors:  Jamie Harris; Samuel C Klonoski; Bill Chiu
Journal:  Curr Drug Deliv       Date:  2017       Impact factor: 3.758

5.  Enhancing the anti-colon cancer activity of quercetin by self-assembled micelles.

Authors:  Guangya Xu; Huashan Shi; Laibin Ren; Hongfeng Gou; Daoyin Gong; Xiang Gao; Ning Huang
Journal:  Int J Nanomedicine       Date:  2015-03-16

6.  PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression.

Authors:  Neera Yadav; Amit Kumar Tripathi; Amna Parveen
Journal:  Pharmaceutics       Date:  2022-06-23       Impact factor: 6.525

Review 7.  Zebrafish models for functional and toxicological screening of nanoscale drug delivery systems: promoting preclinical applications.

Authors:  Keon Yong Lee; Gun Hyuk Jang; Cho Hyun Byun; Minhong Jeun; Peter C Searson; Kwan Hyi Lee
Journal:  Biosci Rep       Date:  2017-06-08       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.